Evidence map›Paper›PMID 41440602›Full record

ArticleInfectious disease reports2025

Beyond the Spike Glycoprotein: Mutational Signatures in SARS-CoV-2 Structural Proteins.

Emil Tonon, Riccardo Cecchetto, Virginia Lotti, Anna Lagni, Erica Diani, Asia Palmisano, Marco Mantoan, Livio Montesarchio, Francesca Palladini, Giona Turri and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infectious disease reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Emil TononDepartment of Diagnostic and Public Health, Division of Microbiology, University of Verona, 37134 Verona, Italy.
Riccardo CecchettoDepartment of Diagnostic and Public Health, Division of Microbiology, University of Verona, 37134 Verona, Italy.ORCID 0009-0000-5189-8867
Virginia LottiDepartment of Diagnostic and Public Health, Division of Microbiology, University of Verona, 37134 Verona, Italy.ORCID 0000-0002-5746-3810
Anna LagniDepartment of Diagnostic and Public Health, Division of Microbiology, University of Verona, 37134 Verona, Italy.ORCID 0009-0005-1044-3109
Erica DianiDepartment of Diagnostic and Public Health, Division of Microbiology, University of Verona, 37134 Verona, Italy.ORCID 0000-0002-1373-7533
Asia PalmisanoDepartment of Diagnostic and Public Health, Division of Microbiology, University of Verona, 37134 Verona, Italy.
Marco MantoanDepartment of Diagnostic and Public Health, Division of Hygiene and Preventive, Environmental and Occupational Medicine, University of Verona, 37134 Verona, Italy.
Livio MontesarchioHospital Management, University Hospital of Verona, 37126 Verona, Italy.ORCID 0009-0001-4982-4153
Francesca PalladiniHospital Management, University Hospital of Verona, 37126 Verona, Italy.
Giona TurriUOC Microbiology, AOUI Verona, 37134 Verona, Italy.
Davide GibelliniDepartment of Diagnostic and Public Health, Division of Microbiology, University of Verona, 37134 Verona, Italy.

Funding

University of Verona Quota FUR Davide Gibellini, Quota FUR Erica Diani, Quota FUR Virginia Lotti
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

genomic surveillancemutational analysisSARS-CoV-2structural proteinwhole genome sequencing

Identifiers

PMID41440602
PMCPMC12733084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.